FDA Approval Summary: Olaparib Monotherapy in Patients with...

  • Main
  • 2015 / 07
  • FDA Approval Summary: Olaparib Monotherapy in Patients with...

FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy

Kim, G., Ison, G., McKee, A. E., Zhang, H., Tang, S., Gwise, T., Sridhara, R., Lee, E., Tzou, A., Philip, R., Chiu, H.-J., Ricks, T. K., Palmby, T., Russell, A. M., Ladouceur, G., Pfuma, E., Li, H., Z
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-0887
Date:
July, 2015
File:
PDF, 214 KB
english, 2015
Conversion to is in progress
Conversion to is failed